Cramer Rosenthal McGlynn
Mutual Funds

Performance

Quarter-End

as of September 30, 2025
Our Funds Q3'25 YTD 1YR 3YR 5YR 10YR Since Inception2 Inception Date Net Expense Ratio Gross Expense Ratio1
CRM Long/Short Opportunities  
CRIHX - Institutional Shares 2.83% -4.03% -2.54% 8.05% 5.72% 5.04% August 16, 2016 1.87% 2.02%
S&P 500 8.12% 14.83% 17.60% 24.94% 16.47% 15.04%
CRM Small Cap Value  
CRISX - Institutional Shares 4.61% -2.38% 0.54% 11.65% 13.33% 7.96% 8.28% January 27, 1998 1.10% 1.10%
CRMSX - Investor Shares 4.50% -2.46% 0.37% 11.43% 13.11% 7.73% 9.48% October 1, 1995 1.28% 1.28%
Russell 2000 Value Index 12.60% 9.04% 7.88% 13.56% 14.59% 9.23% 9.25%
CRM Small/Mid Cap Value  
CRIAX - Institutional Shares 6.58% -2.02% -0.95% 10.85% 12.35% 9.79% 9.18% September 1, 2004 1.07% 1.07%
CRMAX - Investor Shares 6.54% -2.22% -1.15% 10.66% 12.14% 9.57% 8.95% September 1, 2004 1.24% 1.24%
Russell 2500 Value Index 8.17% 9.29% 9.00% 15.39% 14.96% 9.68% 8.68%
CRM Mid Cap Value  
CRIMX - Institutional Shares 6.82% 4.66% 1.18% 10.58% 11.85% 10.11% 10.61% January 6, 1998 1.04% 1.04%
CRMMX - Investor Shares 6.81% 4.55% 1.03% 10.41% 11.66% 9.91% 9.79% September 20, 2000 1.20% 1.20%
Russell Midcap Value Index 6.18% 9.50% 7.58% 15.51% 13.66% 9.96% 9.30%
CRM All Cap Value  
CRIEX - Institutional Shares 8.13% 4.20% 3.73% 12.14% 12.14% 9.26% 7.03% October 24, 2006 1.21% 1.26
CRMEX - Investor Shares 8.02% 3.93% 3.51% 11.84% 11.86% 8.99% 6.77% October 24, 2006 1.46% 1.49%
Russell 3000 Value Index 5.63% 11.49% 9.33% 16.76% 13.92% 10.63% 7.64%

Month-End

as of November 30, 2025
Our Funds NOV'25 YTD 1YR 3YR 5YR 10YR Since Inception2 Inception Date Net Expense Ratio Gross Expense Ratio1
CRM Long/Short Opportunities  
CRIHX – Institutional Shares 1.61% -2.17% -4.62% 6.33% 5.36% 5.17% August 16, 2016 1.87% 2.02%
S&P 500 0.25% 17.81% 15.00% 20.57% 15.28% 15.07%
CRM Small Cap Value  
CRISX - Institutional Shares 5.03% 1.70% -5.63% 7.34% 9.53% 7.45% 8.39% January 27, 1998 1.10% 1.10%
CRMSX - Investor Shares 5.02% 1.59% -5.77% 7.15% 9.31% 7.22% 9.57% October 1, 1995 1.28% 1.28%
Russell 2000 Value Index 2.81% 12.39% 3.02% 9.17% 10.51% 8.66% 9.31%
CRM Small/Mid Cap Value  
CRIAX - Institutional Shares 4.69% 3.68% -2.47% 7.81% 9.94% 9.64% 9.39% September 1, 2004 1.07% 1.07%
CRMAX - Investor Shares 4.58% 3.42% -2.68% 7.63% 9.74% 9.42% 9.16% September 1, 2004 1.24% 1.24%
Russell 2500 Value Index 2.88% 12.14% 4.09% 10.73% 11.39% 9.15% 8.74%
CRM Mid Cap Value  
CRIMX - Institutional Shares 2.27% 7.08% -0.40% 5.82% 9.15% 9.57% 10.63% January 6, 1998 1.04% 1.04%
CRMMX - Investor Shares 2.29% 6.95% -0.56% 5.64% 8.98% 9.37% 9.82% September 20, 2000 1.20% 1.20%
Russell Midcap Value Index 2.39% 10.98% 2.86% 10.32% 10.81% 9.43% 9.29%
CRM All Cap Value  
CRIEX - Institutional Shares 1.85% 7.83% 2.55% 7.67% 9.31% 8.74% 7.16% October 24, 2006 1.21% 1.26
CRMEX - Investor Shares 1.93% 7.57% 2.31% 7.40% 9.04% 8.47% 6.90% October 24, 2006 1.46% 1.49%
Russell 3000 Value Index 2.66% 14.96% 7.01% 11.92% 11.93% 10.12% 7.74%

Daily

as of December 4, 2025
Our Funds Current Price Change YTD Inception Date Net Expense Ratio Gross Expense Ratio1
CRM Long/Short Opportunities  
CRIHX - Institutional Shares 12.68 -0.08% -1.63% August 16, 2016 1.87% 2.02%
CRM Small Cap Value  
CRISX - Institutional Shares 16.76 -0.42% 2.68% January 27, 1998 1.10% 1.10%
CRMSX - Investor Shares 12.79 -0.39% 2.56% October 1, 1995 1.28% 1.28%
CRM Small/Mid Cap Value  
CRIAX - Institutional Shares 11.33 0.00% 4.52% September 1, 2004 1.07% 1.07%
CRMAX - Investor Shares 10.74 0.00% 4.33% September 1, 2004 1.24% 1.24%
CRM Mid Cap Value  
CRIMX - Institutional Shares 23.20 0.22% 8.15% January 6, 1998 1.04% 1.04%
CRMMX - Investor Shares 21.65 0.23% 8.03% September 20, 2000 1.20% 1.20%
CRM All Cap Value  
CRIEX - Institutional Shares 7.20 0.42% 9.96% October 24, 2006 1.21% 1.26
CRMEX - Investor Shares 6.87 0.44% 9.64% October 24, 2006 1.46% 1.49%

Shares of CRM Funds are distributed by ALPS Distributors, Inc.

Cramer Rosenthal McGlynn, LLC is the investment advisor to the CRM Funds and is not affiliated with ALPS.